FindTrial
Sign In

The role of MRTF-A-mediated macrophage polarization in endometriosis disease

The role of MRTF-A-mediated macrophage polarization in endometriosis disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101489
Enrollment
Unknown
Registered
2025-04-25
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Endometriosis group:None
Gynecologic benign disease group:None

Sponsors

Hebei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1.Those who meet the diagnostic criteria, voluntarily participate in this study; 2. Age range from 20 to 49 years old; 3. Not taking hormone drugs for EMS treatment in the first 1 months before enrollment; 4. Pathological diagnosis confirmed EMS.

Exclusion criteria

Exclusion criteria: 1. Combined pelvic infection and malignant tumor; 2. Merge cardiovascular, cerebrovascular, liver, kidney, and hematological diseases; 3. Individuals with combined mental and neurological disorders.

Design outcomes

Primary

MeasureTime frame
MRTF-A;SRF;BRG1;CD206;—

Secondary

MeasureTime frame
TNF-a;Arg-1;VEGF;IL-1ß;IL-10;iNOS;TGF-ß;—

Countries

China

Contacts

Public ContactChen Jingwei

Hebei University of Chinese Medicine

chenjingwei2024@126.com+86 311 8992 6300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026